Loading…

Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007

Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobia...

Full description

Saved in:
Bibliographic Details
Published in:Annals of Saudi medicine 2010-09, Vol.30 (5), p.358-363
Main Authors: Al-Talib, Hassanain I, Yean, Chan Y, Al-Jashamy, Karim, Hasan, Habsah
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223
cites cdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223
container_end_page 363
container_issue 5
container_start_page 358
container_title Annals of Saudi medicine
container_volume 30
creator Al-Talib, Hassanain I
Yean, Chan Y
Al-Jashamy, Karim
Hasan, Habsah
description Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility. This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years. The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P>.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin. The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM.
doi_str_mv 10.4103/0256-4947.67077
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_be228b5ec5e346bb87720866da425465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A235994172</galeid><doaj_id>oai_doaj_org_article_be228b5ec5e346bb87720866da425465</doaj_id><sourcerecordid>A235994172</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIlsKZG4rg0FO2_nZyQaoqSiu14lB6thx7sutV1l5sp9Je-O043bZiEbLksWbevPnwq6qPGC0YRvQMES4a1jG5EBJJ-ao6Rp3kDWNCvC7v5-hR9S6lNUIEMUrfVkcEiU5iiY-r37eQV864cXS-iZBcytrn-i7r7Wo3BhOMmVKtpwjF-JCKZ-P0WDs_gMku-DpH8DYVR30V0tblErz37gFictnVd9r5VN_qUe-S07WdovPLmpRWmnLJ99WbQY8JPjzZk-r-8tvPi6vm5sf364vzm8ZwjHNDh6HDjBHLewAOgvddSzEMFDi30pDOSiltZxllZTSpQUtOREtbgwaOCKEn1fWe1wa9VtvoNjruVNBOPTpCXCodszMjqB4IaXsOhgNlou9bKQlqhbCaEc4EL1xf91zbqd-ANeBz1OMB6WHEu5VahgdFOoYJk4Xg9Ikghl8TpKw2LhkYR-0hTElJzhBiGIuC_PwPch2m6MumVMsLpMMIF9CXPWipS_vlY0KpamZKdU4o70pVOW9g8R9UORY2zgQPgyv-g4SzfYKJIaUIw8uEGKlZfGqWl5rlpR7FVzI-_b2YF_yz2ugfChLTcQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>850419101</pqid></control><display><type>article</type><title>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</title><source>PubMed Central</source><creator>Al-Talib, Hassanain I ; Yean, Chan Y ; Al-Jashamy, Karim ; Hasan, Habsah</creator><creatorcontrib>Al-Talib, Hassanain I ; Yean, Chan Y ; Al-Jashamy, Karim ; Hasan, Habsah</creatorcontrib><description>Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility. This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years. The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P&gt;.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin. The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM.</description><identifier>ISSN: 0256-4947</identifier><identifier>EISSN: 0975-4466</identifier><identifier>DOI: 10.4103/0256-4947.67077</identifier><identifier>PMID: 20697171</identifier><language>eng</language><publisher>Saudi Arabia: Medknow Publications and Media Pvt. Ltd</publisher><subject>Adult ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Cross Infection - drug therapy ; Cross Infection - epidemiology ; Cross Infection - prevention &amp; control ; Diagnosis ; Disease Transmission, Infectious - statistics &amp; numerical data ; Drug resistance in microorganisms ; Drug therapy ; Epidemiology ; Erythromycin - pharmacology ; Female ; Gentamicins - pharmacology ; Gram-positive bacteria ; Health aspects ; Hospitals ; Humans ; Incidence ; Infections ; Length of Stay ; Logistic Models ; Malaysia - epidemiology ; Methicillin-Resistant Staphylococcus aureus ; Microbial Sensitivity Tests ; Mortality ; Nosocomial infections ; Original ; Penicillin G - pharmacology ; Prevalence studies (Epidemiology) ; Regression analysis ; Risk Factors ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - prevention &amp; control ; Staphylococcus aureus infections ; Staphylococcus infections ; Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology ; Vancomycin - pharmacology</subject><ispartof>Annals of Saudi medicine, 2010-09, Vol.30 (5), p.358-363</ispartof><rights>COPYRIGHT 2010 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt. Ltd. Sep 2010</rights><rights>Annals of Saudi Medicine 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</citedby><cites>FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941247/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941247/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20697171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Talib, Hassanain I</creatorcontrib><creatorcontrib>Yean, Chan Y</creatorcontrib><creatorcontrib>Al-Jashamy, Karim</creatorcontrib><creatorcontrib>Hasan, Habsah</creatorcontrib><title>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</title><title>Annals of Saudi medicine</title><addtitle>Ann Saudi Med</addtitle><description>Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility. This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years. The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P&gt;.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin. The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Cross Infection - drug therapy</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - prevention &amp; control</subject><subject>Diagnosis</subject><subject>Disease Transmission, Infectious - statistics &amp; numerical data</subject><subject>Drug resistance in microorganisms</subject><subject>Drug therapy</subject><subject>Epidemiology</subject><subject>Erythromycin - pharmacology</subject><subject>Female</subject><subject>Gentamicins - pharmacology</subject><subject>Gram-positive bacteria</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infections</subject><subject>Length of Stay</subject><subject>Logistic Models</subject><subject>Malaysia - epidemiology</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Microbial Sensitivity Tests</subject><subject>Mortality</subject><subject>Nosocomial infections</subject><subject>Original</subject><subject>Penicillin G - pharmacology</subject><subject>Prevalence studies (Epidemiology)</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - prevention &amp; control</subject><subject>Staphylococcus aureus infections</subject><subject>Staphylococcus infections</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology</subject><subject>Vancomycin - pharmacology</subject><issn>0256-4947</issn><issn>0975-4466</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIlsKZG4rg0FO2_nZyQaoqSiu14lB6thx7sutV1l5sp9Je-O043bZiEbLksWbevPnwq6qPGC0YRvQMES4a1jG5EBJJ-ao6Rp3kDWNCvC7v5-hR9S6lNUIEMUrfVkcEiU5iiY-r37eQV864cXS-iZBcytrn-i7r7Wo3BhOMmVKtpwjF-JCKZ-P0WDs_gMku-DpH8DYVR30V0tblErz37gFictnVd9r5VN_qUe-S07WdovPLmpRWmnLJ99WbQY8JPjzZk-r-8tvPi6vm5sf364vzm8ZwjHNDh6HDjBHLewAOgvddSzEMFDi30pDOSiltZxllZTSpQUtOREtbgwaOCKEn1fWe1wa9VtvoNjruVNBOPTpCXCodszMjqB4IaXsOhgNlou9bKQlqhbCaEc4EL1xf91zbqd-ANeBz1OMB6WHEu5VahgdFOoYJk4Xg9Ikghl8TpKw2LhkYR-0hTElJzhBiGIuC_PwPch2m6MumVMsLpMMIF9CXPWipS_vlY0KpamZKdU4o70pVOW9g8R9UORY2zgQPgyv-g4SzfYKJIaUIw8uEGKlZfGqWl5rlpR7FVzI-_b2YF_yz2ugfChLTcQ</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Al-Talib, Hassanain I</creator><creator>Yean, Chan Y</creator><creator>Al-Jashamy, Karim</creator><creator>Hasan, Habsah</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>KING FAISAL SPECIALIST HOSPITAL &amp; RESEARCH CENTRE</general><general>Medknow Publications</general><general>King Faisal Specialist Hospital and Research Centre</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20100901</creationdate><title>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</title><author>Al-Talib, Hassanain I ; Yean, Chan Y ; Al-Jashamy, Karim ; Hasan, Habsah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Cross Infection - drug therapy</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - prevention &amp; control</topic><topic>Diagnosis</topic><topic>Disease Transmission, Infectious - statistics &amp; numerical data</topic><topic>Drug resistance in microorganisms</topic><topic>Drug therapy</topic><topic>Epidemiology</topic><topic>Erythromycin - pharmacology</topic><topic>Female</topic><topic>Gentamicins - pharmacology</topic><topic>Gram-positive bacteria</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infections</topic><topic>Length of Stay</topic><topic>Logistic Models</topic><topic>Malaysia - epidemiology</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Microbial Sensitivity Tests</topic><topic>Mortality</topic><topic>Nosocomial infections</topic><topic>Original</topic><topic>Penicillin G - pharmacology</topic><topic>Prevalence studies (Epidemiology)</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - prevention &amp; control</topic><topic>Staphylococcus aureus infections</topic><topic>Staphylococcus infections</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology</topic><topic>Vancomycin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Talib, Hassanain I</creatorcontrib><creatorcontrib>Yean, Chan Y</creatorcontrib><creatorcontrib>Al-Jashamy, Karim</creatorcontrib><creatorcontrib>Hasan, Habsah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep (ProQuest)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of Saudi medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Talib, Hassanain I</au><au>Yean, Chan Y</au><au>Al-Jashamy, Karim</au><au>Hasan, Habsah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007</atitle><jtitle>Annals of Saudi medicine</jtitle><addtitle>Ann Saudi Med</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>30</volume><issue>5</issue><spage>358</spage><epage>363</epage><pages>358-363</pages><issn>0256-4947</issn><eissn>0975-4466</eissn><abstract>Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide. The aim of the present study was to assess the burden of MRSA nosocomial infection, its association with factors of interest, and its antimicrobial susceptibility. This was a retrospective analysis of a database of all S aureus that were cultured from patients admitted to the different wards of Hospital Universiti Sains Malaysia (HUSM) over a period of 6 years. The MRSA infections rate was 10.0 per 1000 hospital admissions. The incidence density rate of MRSA infections during the study period was 1.8 per 1000 patient-days, with annual rates ranging from 0.95 to 3.47 per 1000 patient-days. Duration of hospitalization, previous antibiotic use, and bedside invasive procedures were significantly higher among MRSA than methicillin-sensitive S aureus patients (P&gt;.05). The highest number of MRSA infections were found in orthopedic wards (25.3%), followed by surgical wards (18.2%) and intensive care units (ICUs) (16.4%). All MRSA isolates were resistant to erythromycin (98.0%), co-trimoxazole (94.0%) and gentamicin (92.0%). Clindamycin was the best antibiotic with only 6% resistance. All MRSA isolates were sensitive to vancomycin. The rate of nosocomial MRSA infection per 1000 admissions was higher than that in other studies. The three factors associated most significantly with acquired MRSA infections included duration of hospitalization, antibiotic use, and bedside invasive procedures. This study confirmed that vancomycin-resistant S aureus has not yet been established in HUSM.</abstract><cop>Saudi Arabia</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>20697171</pmid><doi>10.4103/0256-4947.67077</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0256-4947
ispartof Annals of Saudi medicine, 2010-09, Vol.30 (5), p.358-363
issn 0256-4947
0975-4466
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_be228b5ec5e346bb87720866da425465
source PubMed Central
subjects Adult
Anti-Bacterial Agents - pharmacology
Antibiotics
Cross Infection - drug therapy
Cross Infection - epidemiology
Cross Infection - prevention & control
Diagnosis
Disease Transmission, Infectious - statistics & numerical data
Drug resistance in microorganisms
Drug therapy
Epidemiology
Erythromycin - pharmacology
Female
Gentamicins - pharmacology
Gram-positive bacteria
Health aspects
Hospitals
Humans
Incidence
Infections
Length of Stay
Logistic Models
Malaysia - epidemiology
Methicillin-Resistant Staphylococcus aureus
Microbial Sensitivity Tests
Mortality
Nosocomial infections
Original
Penicillin G - pharmacology
Prevalence studies (Epidemiology)
Regression analysis
Risk Factors
Staphylococcal Infections - drug therapy
Staphylococcal Infections - epidemiology
Staphylococcal Infections - prevention & control
Staphylococcus aureus infections
Staphylococcus infections
Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology
Vancomycin - pharmacology
title Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methicillin-resistant%20Staphylococcus%20aureus%20nosocomial%20infection%20trends%20in%20Hospital%20Universiti%20Sains%20Malaysia%20during%202002-2007&rft.jtitle=Annals%20of%20Saudi%20medicine&rft.au=Al-Talib,%20Hassanain%20I&rft.date=2010-09-01&rft.volume=30&rft.issue=5&rft.spage=358&rft.epage=363&rft.pages=358-363&rft.issn=0256-4947&rft.eissn=0975-4466&rft_id=info:doi/10.4103/0256-4947.67077&rft_dat=%3Cgale_doaj_%3EA235994172%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-3ff91442d5bee5e65b9831ef3e55d7c29d777d9d4342067aea7526838c0f50223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=850419101&rft_id=info:pmid/20697171&rft_galeid=A235994172&rfr_iscdi=true